Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI)

NCT ID: NCT00741494

Last Updated: 2010-12-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

801 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if using microdots of hyaluronan (PICSI) to select sperm for ICSI will result in increased pregnancies especially with men that have a low hyaluronan binding score (HBA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Male Factor Infertility

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

infertility ICSI hyaluronan binding sperm sperm selection male factor hyaluronan sperm maturity clinical pregnancy rates hyaluronan binding assay HBA PICSI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

HBA score over 65% control

Group Type NO_INTERVENTION

No interventions assigned to this group

2

HBA score over 65%, non-participant (to even out the participation between patients with low HBA scores and those with high HBA scores)

Group Type NO_INTERVENTION

No interventions assigned to this group

3

HBA score over 65%. PICSI dish is used to select the sperm for ICSI.

Group Type ACTIVE_COMPARATOR

PICSI dish

Intervention Type DEVICE

Sperm are added to the PICSI dish. Only those that bind to the hyaluronan microdots are selected for ICSI

4

HBA score less than 65%. PICSI dish used to select sperm for ICSI.

Group Type EXPERIMENTAL

PICSI dish

Intervention Type DEVICE

Sperm are added to the PICSI dish. Only those that bind to the hyaluronan microdots are selected for ICSI

5

HBA Score less than 65%. Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PICSI dish

Sperm are added to the PICSI dish. Only those that bind to the hyaluronan microdots are selected for ICSI

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* IVF patients who require the ICSI procedure and whose care is being managed by the clinical and scientific staff of the participating groups, will be included in the study.

Exclusion Criteria

* IVF patients who do not require the ICSI procedure will be excluded from the study. In addition the following groups of patients will also be excluded:

* Patients using testicular sperm.
* Patients using donor sperm.
* Patients where the female partner is over 40 years of age
* Patients who have an initial HBA score less than or equal to 2%
* Patients who have a sperm count less than or equal to 10,000 motile sperm per ml.
* Patients who produce less than 4 Metaphase II oocytes
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biocoat

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Biocoat, Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kathryn Worrilow, Ph.D.

Role: STUDY_DIRECTOR

Biocoat

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Huntington Reproductive Center

Laguna Hills, California, United States

Site Status

Reproductive Science Center of the Bay Area

San Ramon, California, United States

Site Status

Georgia Reproductive Specialists

Atlanta, Georgia, United States

Site Status

Reproductive Biology Associates

Atlanta, Georgia, United States

Site Status

Fertility Centers of Illinois

Chicago, Illinois, United States

Site Status

CNY Fertility Center

Syracuse, New York, United States

Site Status

Abington IVF and Genetics Toll Center for Reprodcution

Abington, Pennsylvania, United States

Site Status

Center for Reproduction and Infertility, Women and Infants Hospital of Rhode Island

Providence, Rhode Island, United States

Site Status

Seattle Reproductive Medicine

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Worrilow KC, Eid S, Woodhouse D, Perloe M, Smith S, Witmyer J, Ivani K, Khoury C, Ball GD, Elliot T, Lieberman J. Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes--multicenter, double-blinded and randomized controlled trial. Hum Reprod. 2013 Feb;28(2):306-14. doi: 10.1093/humrep/des417. Epub 2012 Nov 30.

Reference Type DERIVED
PMID: 23203216 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008PICSI03

Identifier Type: -

Identifier Source: org_study_id